- Home
- NEOV vs IOBT Comparison
NEOV vs IOBT Comparison
Compare NEOV & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- IOBT
- Stock Information
- Founded
- NEOV 2018
- IOBT 2014
- Country
- NEOV United States
- IOBT Denmark
- Employees
- NEOV N/A
- IOBT N/A
- Industry
- NEOV Industrial Machinery/Components
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- NEOV Miscellaneous
- IOBT Health Care
- Exchange
- NEOV Nasdaq
- IOBT Nasdaq
- Market Cap
- NEOV 72.2M
- IOBT 79.7M
- IPO Year
- NEOV N/A
- IOBT 2021
- Fundamental
- Price
- NEOV $3.24
- IOBT $1.62
- Analyst Decision
- NEOV Strong Buy
- IOBT Strong Buy
- Analyst Count
- NEOV 1
- IOBT 3
- Target Price
- NEOV $7.50
- IOBT $9.33
- AVG Volume (30 Days)
- NEOV 176.1K
- IOBT 171.8K
- Earning Date
- NEOV 05-09-2025
- IOBT 05-14-2025
- Dividend Yield
- NEOV N/A
- IOBT N/A
- EPS Growth
- NEOV N/A
- IOBT N/A
- EPS
- NEOV N/A
- IOBT N/A
- Revenue
- NEOV $4,255,136.00
- IOBT N/A
- Revenue This Year
- NEOV $208.50
- IOBT N/A
- Revenue Next Year
- NEOV $128.75
- IOBT N/A
- P/E Ratio
- NEOV N/A
- IOBT N/A
- Revenue Growth
- NEOV 52.64
- IOBT N/A
- 52 Week Low
- NEOV $1.80
- IOBT $0.66
- 52 Week High
- NEOV $6.11
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- NEOV 53.45
- IOBT 80.12
- Support Level
- NEOV $2.76
- IOBT $1.09
- Resistance Level
- NEOV $3.74
- IOBT $1.29
- Average True Range (ATR)
- NEOV 0.33
- IOBT 0.12
- MACD
- NEOV -0.01
- IOBT 0.05
- Stochastic Oscillator
- NEOV 48.98
- IOBT 95.84
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.